We show that Indian Hedgehog (Ihh) regulates T-cell development and homeostasis in both fetal and adult thymus, controlling thymocyte number. 
Introduction
Here we show that the intercellular signaling molecule, Indian Hedgehog (Ihh), regulates T-cell development, thereby restricting thymocyte number Thymus size is tightly controlled by processes intrinsic to the thymus, about which little is known. The control of thymocyte number has been assumed to rely on competition between thymocyte precursors for limiting concentrations of mitogenic or survival factors, that by positively regulating the fate of the progenitor cell population control the number of thymocytes produced. Many factors have been described that promote the expansion of thymocyte progenitors and promote T-cell development, including cytokines, 1 Notch signaling, 2 , 3 the Wnt protein family, 4 and Sonic Hh (Shh). 5 Little, however, is understood about mechanisms that provide feedback, or a counting system, negatively regulating the upper limits of thymocyte differentiation and number. Here we show that Ihh provides such a counting system, negatively regulating the rate of differentiation from CD4 − CD8 − double-negative (DN) to CD4 + CD8 + double-positive (DP) cell, and hence T-cell production and thymus size.
The Hh protein family (Shh, Ihh, and Desert Hh [Dhh] ) signals for development, patterning, and organogenesis of many tissues during mammalian embryogenesis 6 , 7 and is also involved in homeostasis and renewal of adult tissues, including blood and thymus. 8 -11 They can act as classic morphogens, giving concentration-dependent signals for position and patterning, and can regulate cell survival and proliferation. 6 , 7 The 3 Hh proteins have distinct temporal and tissue-specific expression patterns and functions. 12 , 13 Although Shh and Ihh are each essential during embryogenesis and have some overlapping functions, 14 Shh is more pleiotropic and nonredundant in its actions, whereas Ihh has specialized functions in bone, cartilage, and gut. 13 - 15 The Hh proteins share a common signaling pathway.
They bind to the receptor Patched (Ptc), which releases the signal transduction protein Smoothened (Smo) to transmit a signal into the cell. In the absence of Hh, Ptc inhibits the activity of Smo. The downstream components of the signaling pathway are the glioblastoma-associated protein (Gli) family of transcription factors: Gli1, Gli2, and Gli3. 7 , 16 During αβ T-cell development, CD4 − CD8 − DN cells give rise to the CD4 + CD8 + DP population, which differentiate to mature CD8 + CD4 − or CD8 − CD4 + single-positive (SP) cells. The DN population can be further subdivided by cell-surface expression of CD25 and CD44. CD44 + CD25 − (DN1) cells differentiate to become CD44 + CD25 + (DN2) cells, which then differentiate to become CD44 − CD25 + (DN3). The DN3 population gives rise to the CD44 − CD25 − (DN4) subset, which undergo a phase of rapid proliferation before differentiation into the DP population, in general via a cycling immature CD8 + intermediate single-positive (ISP) cell. T-cell lineage specification and T-cell receptor-β (TCR-β) chain rearrangements occur in the CD25 + (DN2 and DN3) population. Pre-TCR signaling is necessary for differentiation to DP cell, 17 but other largely unidentified signals dependent on normal thymus architecture and cellular composition are also required. 18 Shh, Ihh, and components of the Hh signaling pathway are expressed in the mouse thymus. 10 , 19 -23 In vitro studies first demonstrated that Hh signaling influences thymocyte development, 10 , 24 and although they did not determine which Hh protein (Shh or Ihh) was physiologically significant, suggested that
Hh signaling was predominantly a negative regulator of T-cell development.
In contrast, subsequent ex vivo analysis of Shh −/− thymi revealed multiple positive-regulatory functions for Shh during fetal T-cell development.
Absence of Shh caused reductions in thymocyte number, DN cell proliferation, differentiation from DN1 to DN2 cell, survival of DN4 cells, production of DP cells, 5 and the ratio of mature CD8/CD4 SP cells. 22 , 25 , 26 Conditional deletion of Smo from T-lineage cells has also shown that the Hh pathway provides essential positive signals for homeostasis of the earliest DN subsets and for differentiation from DN1 to DN2 but did not reveal any influence of Hh signaling on T-cell development after the DN2 stage. 21 Here we take a genetic approach to assess the function of Ihh during thymocyte development, thereby reconciling conflicting data from earlier experimental systems. 5 , 10 , 21 , 23 , 24 We demonstrate, by analysis of null and conditional-null mutants, that Ihh, produced by thymocytes themselves, regulates T-cell development and homeostasis in fetal and adult thymus. We show that Ihh and Shh have distinct but overlapping functions in the thymus, and that whereas Shh, secreted by the epithelium, is dominant in positively signaling for proliferation and differentiation of early DN progenitors, Ihh, produced by thymocytes, functions to control thymocyte numbers by negatively regulating the transition from icTCR-β+ DN3 to DP, providing concentration-dependent feedback on the production of DP cells. 
Methods

Mice
Fetal thymus organ cultures
Fetal thymus organ cultures (FTOCs) were as described. 
Flow cytometry and antibodies
Thymi were dissected, and cell suspensions were prepared, stained, and analyzed as described, 5 , 28 
Genotyping and PCR analysis
Ihh −/− embryos die around birth, and from E16.5 can be identified phenotypically by their shortened limbs and slightly small size, whereas Ihh +/− embryos and adults are healthy and phenotypically indistinguishable from WT. 13 In addition to phenotypic identification, all embryos and animals were genotyped by polymerase chain reaction (PCR).
DNA extraction and PCR analysis were as described, 
Real-time RT-PCR
RNA extraction and cDNA synthesis were as described. 23 One primer for each pair was designed to span exon-exon boundaries to avoid amplification of genomic DNA. Primers: Ihh, forward: CGACATCATCTTCAAGGACG, reverse: GTCACCCGCAGTTTCACAC; HPRT and Gli1 as described.
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Quantitative PCR of VDJ TCR-β rearrangement TCR-β VDJ rearrangement measurement was carried out as described.
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Results
Expression of Ihh and Gli1 in thymus populations
We have described Ihh expression in the whole thymus. 10 Here we assess expression of Ihh in fluorescence-activated cell sorter (FACS)-sorted E16.5 fetal thymocyte populations and fetal thymus stroma. We found Ihh expression in both thymus stroma and thymocytes, with highest expression in the DP population. In the sorted thymocyte populations, low Ihh expression, equivalent to that found in the stroma, was detectable in the DN3 population, and relative expression increased 6-fold between the DN3 and DP populations ( Figure 1A ).
Both RT-PCR analysis and cell-surface staining have shown that Smo expression is highest in the CD25 + DN population, and down-regulated in the subsequent DN4 and DP populations, indicating that the DP cells are probably unable to respond to an Hh signal, 10 , 21 and DP cells are not responsive to Shh treatment in vitro. 10 The transcription factor Gli1 is a ubiquitous transcriptional target of Hh signaling but is not necessary to initiate the Hh signal, and measurement of its transcription is used as a readout of Hh signaling in a cell population. 30 Therefore, to determine which fetal thymocyte populations responded to the Hh signal ex vivo, we assessed Gli1 transcription in sorted fetal thymocyte populations. As predicted by the pattern of Smo expression, we found highest Gli1 transcription in the CD25 + DN populations (DN2 and DN3), and Gli1 transcription was down-regulated in the subsequent DN4 and DP populations ( Figure 1B ). This pattern of expression correlates well with the expression of Gli3 and Gli2 in thymocytes, which are both expressed in DN populations but down-regulated at the DP stage, confirming that DP thymocytes cannot transduce the Hh signal. 21 -23 Thus, the DP population had the highest expression of Ihh but did not express significant levels of Gli1, implying that they were not themselves responding to an autocrine Hh signal, but rather signaling back to an earlier cell ( Figure 1A,B) .
Ihh has a redundant function at the transition from DN1 to DN2
To assess the function of Ihh during fetal T-cell development, we studied thymocyte development in Ihh −/− embryos. Given that Smo, Shh, and Gli3 are important for differentiation from DN1 to DN2, 5 , 21 , 23 we investigated a role for Ihh at the same developmental checkpoint. We analyzed E13.5 and E14.5 thymi, when the DN1 to DN2 transition first occurs. On E13.5, Shh −/− thymi had a reduction in cell number, proportion of CD45 + cells, and differentiation from DN1 to DN2. 5 In contrast, we found no differences in the 
Ihh negatively regulates the transition from DN to DP
To determine whether Ihh is important at the transition from DN to DP cell, we compared thymocyte development in E16.5 Ihh −/− , +/− , and WT littermates. As E16.5 is the day of embryonic development on which DP cells first appear, the transition from DN to DP on E16.5 is largely synchronized.
Thymocyte number was reduced in Ihh −/− thymi to less than half of WT littermate thymi, but surprisingly Ihh +/− thymi contained on average 1.4 times more thymocytes than WT thymi, and there was greater variation between individual Ihh +/− thymi ( Figure 3A ). The differences in thymocyte number relative to WT were statistically significant for both Ihh −/− and Ihh +/− embryos and were reflected in the size of the thymus lobes ( Figure 3B ).
In Ihh −/− thymi, the proportion of DP cells was reduced ( Figure 3C ,D). In
Ihh +/− thymi, however, both the proportion and absolute number of DP cells were increased, compared with WT, and on average the Ihh +/− thymus contained 2.4 times more DP cells than WT thymi ( Figure 3C ,D); 6.2% of cells were DP in Ihh −/− thymi compared with 10.4% and 17.3% in WT and 
Ihh is not required for TCR-β locus rearrangement
We found an overall increase in percentage of DN cells but a significant decrease in the proportion of DN4 cells in the Ihh −/− thymus ( Figure 3F ). Because transition to the DP stage requires pre-TCR signaling, the reduced differentiation from DN3 to DP observed in Ihh −/− thymus could be the result of failure to rearrange the TCR-β chain locus. To test this, we assessed the ability of DN3 thymocytes to produce functional TCR-β chain protein by measuring intracellular (ic) TCR-β chain expression. The Ihh −/− DN3 population expressed icTCR-β, and the percentage of icTCR-β + cells in the DN3 population was indeed marginally higher in the Ihh −/− embryos compared with WT littermates ( Figure 3G ,H). We confirmed that TCR-β locus rearrangement was efficient in the Ihh −/− thymus, by quantitative PCR 29 using 5′ primers to Vβ8.2 and Vβ5.1 and a 3′ primer to Jβ2.7 ( Figure 3I ). We found no evidence for reduction in efficiency of TCR-β locus rearrangement between Ihh −/− and WT. Because successful TCR-β locus rearrangement is associated with release from cell-cycle arrest, 31 we also assessed cell-cycle status by propidium iodide (PI) staining of sorted DN3 cells from WT and Ihh −/− littermates. We found no significant difference in the proportion of cells in S + G 2 /M ( Figure 3J ). We therefore found no evidence for a reduction in TCR-β locus rearrangement.
Ihh is a negative regulator of DN3 cell proliferation
To identify the target cell of Ihh's negative regulation of cell number, we sorted CD25 + DN, CD8ISP, and DP populations from E16.5 Ihh +/− and WT thymi and assessed cell-cycle status by PI staining. There was no difference in the percentage of cells in cycle between the DP populations, but the Ihh +/− CD25 + DN population contained significantly more cells in S/G 2 plus M than its WT counterpart, identifying it as a target of Ihh's negative regulation of expansion and differentiation ( Figure 4A ). In addition, a small but significant increase in the proportion of cells in cycle was observed in the Ihh +/− CD8ISP population, relative to WT ( Figure 4A ).
Ihh promotes DN thymocyte development before pre-TCR signal transduction but is a negative regulator after pre-TCR signal transduction
Because thymocytes in Ihh +/− Rag −/− FTOCs increased on average 13 times during the culture period, compared with a 9-fold expansion in the Ihh +/+ Rag −/− FTOCs ( Figure 4C ). This difference was statistically significant (P = .03). Thus, Ihh promoted thymocyte development before pre-TCR signaling but negatively regulated thymocyte development after pre-TCR signaling has taken place.
Ihh regulates fetal thymus homeostasis
We have shown that reduced concentration of Ihh promotes differentiation from DN3 to DP stage and that the DN3 subset is the target population for this negative regulatory function of Ihh ( Figures 3A-F, 4A-C) . In addition, our expression analysis has shown that thymocytes, and in particular the DP population, provide most of the Ihh in the thymus ( Figure 1A ). Concentration of Ihh in the thymus will therefore depend largely on the number of DP thymocytes (ie, Ihh-producing cells). Taken together, our data suggest that
Ihh produced by the thymocytes feeds back to negatively regulate the proliferation and differentiation of DN3 cells after pre-TCR signal transduction, in a concentration-dependent manner. Thus, Ihh signaling in the thymus provides a counting system for post-DN3 thymocyte number.
In the heterozygote fetal thymus, the Ihh +/− thymocytes make half the concentration of Ihh transcript ( Figure 3E ) compared with that of their WT counterparts; thus, the amount of Ihh signaling would be approximately half that observed in the WT thymus. Therefore, given this reduced negative regulatory signal in the Ihh +/− thymus, the target cells will proliferate and differentiate faster. This would result in a larger DP population, thus a larger thymus in total (as observed on E16.5, Figure 3A -E). Once the size of the DP population increases 2-fold, Ihh concentrations will reach WT levels, and so the negative regulatory signal will be fully restored, resulting in a slowdown of proliferation and differentiation. As a consequence, DP production would be reduced, which would then reduce Ihh signal, and the homeostatic cycle would begin again, leading to increased variation in thymocyte number in the heterozygotes.
This model would therefore predict that, on E17.5, the upper limit of size in the Ihh +/− thymus would be greater than in the WT and also that size would be more varied. To test this, we investigated thymocyte differentiation and proliferation on E17.5. As predicted, the Ihh +/− thymi were on average larger, the upper limits of thymus growth were increased 2-fold, and thymocyte number was much more variable (P < .001) than in the WT thymi ( Figure   4D ,E). The proportion of DP cells in the heterozygote thymus also mirrored the increased thymocyte number, with larger thymi containing more DP thymocytes ( Figure 4D ).
Because these data were consistent with concentration-dependent negative feedback on DP cell production, we assessed cell-cycle status of the target cell population of Ihh's negative regulatory action (CD25 + DN thymocytes, 
Distinct and redundant functions for Ihh and Shh on E16.5
To assess redundancy and overlapping functions of Ihh and Shh on the production of DP cells, we studied the effect of removal of one copy of Ihh 
Concentration-dependent regulation of thymocyte development by r-Hh treatment in FTOCs
To determine whether we could reconstitute the Ihh −/− and Ihh +/− thymus with exogenous Hedgehog protein, we treated FTOCs with recombinant Hedgehog (r-Hh). Mammalian Hh proteins are autocatalytically processed to form an active N-terminal fragment, which is highly homologous between Shh and Ihh and between species. 6 , 7 We therefore treated FTOCs with whereas treatment with low concentrations of this protein increased thymocyte production. 5 We therefore titrated the r-mShh-N in WT FTOCs and measured DP cell production after 3 days ( Figure 5D ). The activity of the rmShh-N was very similar in FTOCs to that of the oct-r-hShh-N we had used in previous studies, and at 1.5 μg/mL r-mShh-N arrested thymocyte development at the DN stage, decreasing the number of DP cells 80-fold, whereas, at the lowest concentration we assayed (0.05 μg/mL), we saw a modest increase in the production of DP cells ( Figure 5D ).
We then asked whether treatment of Ihh +/− FTOCs with r-Hh could restore the negative regulatory effect of Ihh on thymocyte development. Because
Ihh +/− thymi contain approximately twice the number of thymocytes as WT thymi on E16.5, we chose a concentration of r-Hh that decreased DP production approximately 2-fold in our titration ( Figure 5D ). In FTOCs, we 
Ihh signaling in the adult heterozygote thymus
To determine whether Ihh is important in the adult thymus, we confirmed Ihh expression in sorted adult thymocyte populations by quantitative RT-PCR.
We detected Ihh transcription in all thymocyte populations, with a 6-fold upregulation between the DN3 and DP populations ( Figure 6A ). Given that the DP population makes up more than 80% of adult thymocytes and expresses more Ihh than other thymocyte populations or the stroma, it produces most of the Ihh protein in the thymus. We also assessed Gli1 expression in sorted adult populations, and as reported previously, 21 , 22 the pattern of Gli1 transcription in adult thymocytes was similar to that in fetal thymocytes, with expression peaking in the CD25 + (DN2/DN3) DN cells and virtually undetectable in the DP population ( Figure 6B ), indicating that adult DP cells, although the major producers of Ihh, are not themselves responding to an Hh signal.
, 21
To determine whether Ihh is also a negative regulator of adult thymus homeostasis, we compared the thymus of adult inbred Ihh +/− and WT littermates. As seen in the fetal heterozygote thymus ( Figures 3A, 4E) , the upper limit to Ihh +/− thymocyte number was approximately 2-fold greater than in the WT littermates ( Figure 6C ), there was more variation between individual thymi, and Ihh transcription in Ihh +/− DP cells was one-half that in Ihh +/+ DP cells ( Figure 6D ), consistent with negative feedback of Ihh from the DP population on their DN progenitors.
Ihh signaling in the adult Ihh conditional knockout thymus
To further study the role of Ihh produced by the thymocytes, rather than the epithelium, on T-cell development in the adult thymus, we used 2 different conditional ("floxed") Ihh mouse models. 15 Excision was mediated by transgenic Cre in either the vav or CD2 transgenic cassettes. 27 The differentiation from DN to DP cell. 10 Likewise, the development of human CD34 + thymocyte progenitors in vitro was accelerated by neutralization of Hh signaling. 24 These observations seemed to conflict with the phenotype of the Shh −/− thymus, which showed reduced differentiation from DN to DP cell. Consistent with our model, in which Ihh production by DP cells feeds back to signal to the DN population, deletion of Smo using transgenic Cre controlled by the CD4 promoter had no effect on T-cell development, confirming that the DP cells are not themselves responding to the Ihh they secrete. 21 The fact that Hh pathway activation in thymocytes increases differentiation and expansion at the earliest stages of their development but reduces differentiation and proliferation at later developmental stages might seem surprising but has parallels in the development of other tissues, such as gut and retina. 32 and so Hh signaling may affect stem, progenitor, and mature cells differently and have opposing effects on cellular processes, depending on the state of differentiation of the cell.
In the future, it will be important to identify the molecular mechanisms and In conclusion, we show that Ihh produced by thymocytes promotes T-cell development before pre-TCR signal transduction and limits T-cell development after pre-TCR signal transduction in a concentration-dependent manner, thereby restricting thymocyte production and thymus size.
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